CorneliaDekkerMD

Pediatric Infectious Disease • Half Moon Bay, CA

Pediatric Vaccinology and Vaccine Preventable Diseases, Perinatal Infections

Professor Emerita, Pediatrics - Infectious Diseases, Stanford University

Join to view full profile

Dr. Dekker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dekker's full profile

Already have an account?

Office
24 Jenna Lane
Half Moon Bay, CA 94019
Phone+1 510-501-6323

Education & Training

Duke University HospitalFellowship, Pediatric Infectious Diseases, 1979 - 1982
Duke University HospitalResidency, Pediatrics, 1976 - 1979
Michigan State University College of Human MedicineClass of 1976

Certifications & Licensure

CA State Medical License 1998 - 2026
NC State Medical License 1977 - 1998
American Board of Pediatrics Pediatrics

Clinical Trials

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009 Start of enrollment: 2009 Jul 01
Completed
Phase 4
The Influence of Chronic CMV Infection on Influenza Vaccine Responses Start of enrollment: 2012 Oct 01
Completed
Phase 4
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014) Start of enrollment: 2011 Aug 01
Completed
Phase 4
Pilot Study in Young Adults to Examine the Kinetics of Changes in the B-cell Repertoire Following TIV Immunization Start of enrollment: 2012 May 01
Completed
Phase 4
Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age Start of enrollment: 2008 Nov 01
Terminated
Phase 4
B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011) Start of enrollment: 2010 Sep 01
Completed
Phase 4
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013 Start of enrollment: 2013 Oct 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010 Start of enrollment: 2010 Sep 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 3, 2011 Start of enrollment: 2011 Sep 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012 Start of enrollment: 2012 Oct 01
Completed
Phase 4
T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 5, 2013 Start of enrollment: 2013 Sep 01
Completed
Phase 4
The Human Mucosal Immune Responses to Influenza Virus (SLVP026) Start of enrollment: 2012 Dec 01
Completed
Phase 4
Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024) Start of enrollment: 2012 Oct 01
Completed
Phase 4
Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032) Start of enrollment: 2015 Sep 01
Terminated
Phase 4
Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029) Start of enrollment: 2014 Sep 17
Completed
Phase 4
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031) Start of enrollment: 2014 Nov 19
Terminated
Phase 4
Genetic and Environmental Factors in the Response to Influenza Vaccination Start of enrollment: 2014 Oct 03
Completed
Phase 1
Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort Start of enrollment: 2017 Sep 19
Completed
Phase 1
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Start of enrollment: 2014 Sep 30
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

99 citations
Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans
Shai S. Shen-Orr, David Furman, Brian A. Kidd, Francois Hadad, Patricia Lovelace
Cell Systems. 2016-10-26
79 citations
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Paul-Henri Lambert, Donna M. Ambrosino, Svein Rune Andersen, Ralph S. Baric, Steven Black
Vaccine. 2020-06-26
215 citations
An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging
Nazish Sayed, Yingxiang Huang, Khiem Van Nguyen, Zuzana Krejciova-Rajaniemi, Anissa P. Grawe
Nature Aging. 2021-07-01

Press Mentions

Immune System “Clock” Predicts Illness and MortalityJuly 12th, 2021
Caffeine May Counter Age-Related InflammationJanuary 17th, 2017
T-cell and General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 2, 2010January 13th, 2017
Join now to see all